CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-20 | RUBINSTEIN JULIE President | Sale | −4,366 | $66.49 | $290K | 10,634 |
| 2021-01-20 | RUBINSTEIN JULIE President | Sale | −4,264 | $67.58 | $288K | 6,370 |
| 2021-01-20 | RUBINSTEIN JULIE President | Sale | −6,370 | $68.34 | $435K | 0 |
| 2021-01-20 | RUBINSTEIN JULIE President | Option exercise · Stock Option (Right to Buy) | −15,000 | 200,000 | ||
| 2021-01-19 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +50,000 | $6.55 | $328K | 50,679 |
| 2021-01-19 | ROBINS HARLAN S Chief Scientific Officer | Sale | −31,146 | $67.02 | $2.1M | 19,533 |
| 2021-01-19 | ROBINS HARLAN S Chief Scientific Officer | Sale | −3,001 | $67.74 | $203K | 16,532 |
| 2021-01-19 | ROBINS HARLAN S Chief Scientific Officer | Sale | −5,701 | $69.26 | $395K | 10,831 |
| 2021-01-19 | ROBINS HARLAN S Chief Scientific Officer | Sale | −8,052 | $69.97 | $563K | 2,779 |
| 2021-01-19 | ROBINS HARLAN S Chief Scientific Officer | Sale | −2,100 | $70.75 | $149K | 679 |
| 2021-01-19 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −50,000 | 350,000 | ||
| 2021-01-19 | ROBINS CHAD M CEO and Chairman | Sale | −8,300 | $70.42 | $584K | 1,769,880 |
| 2021-01-19 | ROBINS CHAD M CEO and Chairman | Sale | −100 | $71.14 | $7K | 1,769,780 |
| 2021-01-19 | Cohen Chad M Chief Financial Officer | Option exercise | +50,000 | $6.32 | $316K | 51,000 |
| 2021-01-19 | Cohen Chad M Chief Financial Officer | Sale | −17,634 | $66.97 | $1.2M | 33,366 |
| 2021-01-19 | Cohen Chad M Chief Financial Officer | Sale | −4,581 | $67.75 | $310K | 28,785 |
| 2021-01-19 | Cohen Chad M Chief Financial Officer | Sale | −6,695 | $69.00 | $462K | 22,090 |
| 2021-01-19 | Cohen Chad M Chief Financial Officer | Sale | −14,201 | $69.74 | $990K | 7,889 |
| 2021-01-19 | Cohen Chad M Chief Financial Officer | Sale | −6,889 | $70.66 | $487K | 1,000 |
| 2021-01-19 | Cohen Chad M Chief Financial Officer | Option exercise · Stock Option (Right To Buy) | −50,000 | 315,000 |
Page 70 of 120 · 2,386 trades